Artwork

Contenido proporcionado por Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman

1:01:40
 
Compartir
 

Manage episode 391922903 series 3369804
Contenido proporcionado por Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode:

First, we will focus on a few abstracts in precursor states, MGUS.

1. New diagnostic criteria for light chain MGUS (IStopMM):

https://ash.confex.com/ash/2023/webprogram/Paper188547.html

https://ash.confex.com/ash/2023/webprogram/Paper182661.html

2. PERSEUS Trial-Dara-VRD vs VRD in newly diagnosed transplant-eligible myeloma:

https://ash.confex.com/ash/2023/webprogram/Paper191911.html

3. ISKIA trial: Isa-KRD vs KRD in newly diagnosed transplant-eligible myeloma:

https://ash.confex.com/ash/2023/webprogram/Paper177546.html

4. Phase 1/2 study for Daratumumab-Venetoclax-Dexamethasone in early relapsed t(11;14) myeloma:

https://ash.confex.com/ash/2023/webprogram/Paper180766.html

5. GMMG Relapse Trial (Long-term follow-up data from randomized controlled trial of salvage transplant in myeloma)


https://ash.confex.com/ash/2023/webprogram/Paper178835.html

6. Overall survival results of KarMMa-3 trial

https://ash.confex.com/ash/2023/webprogram/Paper178933.html

7. GEM2017FIT Trial: Dara-KRd vs KRd vs VMP-RD in non-transplant eligible patients:

https://ash.confex.com/ash/2023/webprogram/Paper179866.html

  continue reading

57 episodios

Artwork
iconCompartir
 
Manage episode 391922903 series 3369804
Contenido proporcionado por Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode:

First, we will focus on a few abstracts in precursor states, MGUS.

1. New diagnostic criteria for light chain MGUS (IStopMM):

https://ash.confex.com/ash/2023/webprogram/Paper188547.html

https://ash.confex.com/ash/2023/webprogram/Paper182661.html

2. PERSEUS Trial-Dara-VRD vs VRD in newly diagnosed transplant-eligible myeloma:

https://ash.confex.com/ash/2023/webprogram/Paper191911.html

3. ISKIA trial: Isa-KRD vs KRD in newly diagnosed transplant-eligible myeloma:

https://ash.confex.com/ash/2023/webprogram/Paper177546.html

4. Phase 1/2 study for Daratumumab-Venetoclax-Dexamethasone in early relapsed t(11;14) myeloma:

https://ash.confex.com/ash/2023/webprogram/Paper180766.html

5. GMMG Relapse Trial (Long-term follow-up data from randomized controlled trial of salvage transplant in myeloma)


https://ash.confex.com/ash/2023/webprogram/Paper178835.html

6. Overall survival results of KarMMa-3 trial

https://ash.confex.com/ash/2023/webprogram/Paper178933.html

7. GEM2017FIT Trial: Dara-KRd vs KRd vs VMP-RD in non-transplant eligible patients:

https://ash.confex.com/ash/2023/webprogram/Paper179866.html

  continue reading

57 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida

Escucha este programa mientras exploras
Reproducir